Varex Imaging Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed on July 11, 2019, by Varex Imaging Corporation. The filing discloses a strategic decision by the Board of Directors to close the Company's Santa Clara facility. This action is part of the ongoing integration of the imaging business acquired from PerkinElmer, Inc. in May 2017.
Key Financial Metrics and Restructuring Costs
The filing details significant one-time costs associated with the facility closure rather than standard operating metrics. Key financial figures include:
- Total Restructuring Charges: Expected range of $20 million to $24 million.
- Future Cash Expenditures: Approximately $8 million to $11 million of the total charges.
- Annual Cost Savings: Projected at $12 million to $16 million.
- Workforce Impact: Elimination of approximately 110 positions.
Material Changes and Cost Breakdown
The material change involves the commitment to cease operations at the Santa Clara facility by the end of December 2020, with all closure activities expected to conclude by March 2021. The anticipated restructuring charges are broken down as follows:
- Accelerated Depreciation: Approximately $6 million.
- Asset Impairment: $6 million to $7 million.
- Employee and Severance Costs: $5 million to $7 million.
- Remaining Lease Obligations: $3 million to $4 million.
Outlook and Management Commentary
Management views this closure as a necessary step to integrate the PerkinElmer acquisition and improve operational efficiency. The primary outlook is the realization of $12 million to $16 million in annual cost savings once the transition is complete. The filing does not provide updated revenue guidance or liquidity metrics beyond the specific cash outflows related to this restructuring event.
Key Facts for Investor Verification
- Verify the timeline for the cessation of Santa Clara operations (end of December 2020) and final closure (March 2021).
- Monitor the actual cash outflow against the projected $8 million to $11 million range.
- Assess the impact of the $20 million to $24 million charge on the Company's quarterly earnings and balance sheet.
- Confirm the realization of the projected $12 million to $16 million in annual cost savings in future reporting periods.